The Republic of Mauritius deposits the instrument of ratification of the African Medicines Agency (AMA)
On September 30, 2021, the Republic of Mauritius became the thirteenth (13th) Member State to deposit the instrument of ratification of the African Medicines Agency (AMA). The country signed the treaty on September 21, 2021 in Addis Ababa and ratified the same day in Port Louis, Mauritius.
The Ambassador of Mauritius to Ethiopia and the African Union HE Mr. Dharmraj Busgeeth deposited the instrument of accession of HE Amira Elfadil Mohammed, Commissioner for Health, Humanitarian Affairs and Social Development, to the AU Commission.
The Commissioner underlined that the establishment of the AMA was an urgent matter due to the COVID-19 pandemic. “AMA play an important regulatory role, encourage local production of medical products and align regulatory policies on the continent, taking advantage of the opportunities offered by the African Continental Free Trade Area (AfCFTA) ”, added the Commissioner.
Speaking on the occasion, Ambassador Dharmraj Busgeeth noted that Mauritius strongly wishes the establishment of AMA as soon as possible, and contribute to the development of vaccine production facilities on the continent.
The filing by Mauritius is in line with the desire of African Heads of State and Government to avoid the existence of falsified products that pose a risk to public health, harm patients and undermine confidence in healthcare delivery systems. health.
AMAThe main function of the AU will be to strengthen the capacity of States Parties and Regional Economic Communities (RECs) recognized by the AU to regulate medical products in order to improve access to quality, safe and effective medical products. on the continent. AMA will also promote and advocate for the adoption of the AU Model Law on the Regulation of Medicinal Products in States Parties and RECs to facilitate regulatory and legal reforms at continental, regional and national levels.
To date, eighteen (18) Member States have ratified the AMA Treaty and thirteen (13) of them deposited the instruments of ratification with the Commission. The AMA The treaty will enter into force 30 days after the 15th instrument of ratification is deposited with the Commission.
Pending the deposit of the 15th instrument of ratification, the Commission invited Member States to submit proposals for hosting the headquarters of the African Medicines Agency. The Commission has also extended the deadline for submitting applications to host the AMA until October 15, 2021, in accordance with the order of the Standing Committee
Committee of Representatives (RPC) on September 6, 2021. The Commission expects the AMA in 2022.
The African Union Commission encourages all its Member States to sign and ratify the Treaty Establishing the AMA in the interest of public health, safety and security. The Treaty is available for signature at the Commission’s headquarters in Addis Ababa, Ethiopia.
About the African Medicines Agency (AMA) The AMA The treaty was adopted by Heads of State and Government at their 32nd Ordinary Session of the Assembly on February 11, 2019 in Addis Ababa, Ethiopia. The African Medicines Agency aspires to provide support for the improvement of weak regulatory systems. AMA build on efforts to harmonize drug regulation in Africa (AMRH) initiative (2009), which is led by the African Union Development Agency – the New Partnership for Africa’s Development (AUDA–NEPAD). The AMRH The initiative provides guidance to regional economic communities (RECs) and regional health organizations (RHOs) recognized by the AU, to facilitate the harmonization of regulatory requirements and practices between national pharmaceutical authorities (NRAs) of states AU members. AMA will be the second specialized health agency of the African Union after the African Centers for Disease Control and Prevention (Africa CDC).
Distributed by APO Group on behalf of the African Union (AU).
Africanews provides APO Group content as a service to its readers, but does not edit the articles it publishes.